Literature DB >> 24704220

Sudden unexpected death in schizophrenia: autopsy findings in psychiatric inpatients.

Petru Ifteni1, Christoph U Correll2, Victoria Burtea1, John M Kane2, Peter Manu3.   

Abstract

Schizophrenia is associated with premature mortality and a high rate of sudden, unexpected deaths. Autopsy data are scant, and in studies using death certificates or root cause assessments, a majority of sudden deaths remained unexplained. In the community, post-mortem data indicate that the most common cause of sudden "natural" death is coronary artery disease. In this study, we used autopsy findings to determine the cause of sudden death in a consecutive cohort of 7189 schizophrenia patients admitted to a free-standing, psychiatric teaching hospital from 1989 to 2013. Medical record review identified 57 patients (0.79%) who died suddenly and unexpectedly during hospitalization. Autopsies were performed in 51 (89.5%) patients (55.9±9.4years, male=56.9%). Autopsy-based causes of sudden death were most commonly cardiovascular disorders (62.8%). Specific causes included myocardial infarction (52.9%), pneumonia (11.8%), airway obstruction (7.8%), myocarditis (5.9%), and dilated cardiomyopathy, hemopericardium, pulmonary embolus, hemorrhagic stroke and brain tumor (2.0% each). The sudden death remained unexplained in 6 (11.8%) patients, 3 of whom had evidence of coronary arteriosclerosis on autopsy. Patients with and without myocardial infarction were similar regarding age, gender, smoking, body mass index and psychotropic treatment (p values≥0.10). In conclusion, sudden cardiac death occurs at a 0.8% rate in a psychiatric hospital, well above general population rates. Autopsy findings indicate that sudden death in schizophrenia is caused by structural cardiovascular, respiratory and neurological abnormalities, with most cases due to acute myocardial infarction. Early recognition and treatment of coronary artery disease must become a clinical priority for all adults with schizophrenia.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autopsy; Mortality; Schizophrenia; Sudden cardiac death

Mesh:

Year:  2014        PMID: 24704220     DOI: 10.1016/j.schres.2014.03.011

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

1.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

2.  Cardiac Sudden Death in Psychiatric Patients.

Authors:  Hiroyuki Uchida; Takefumi Suzuki
Journal:  Can J Psychiatry       Date:  2015-05       Impact factor: 4.356

3.  Medical Rapid Response in Psychiatry: Reasons for Activation and Immediate Outcome.

Authors:  Peter Manu; Kristy Loewenstein; Yankel J Girshman; Padam Bhatia; Maira Barnes; Joseph Whelan; Victoria A Solderitch; Liliana Rogozea; Marybeth McManus
Journal:  Psychiatr Q       Date:  2015-12

4.  Baroreflex Coupling Assessed by Cross-Compression Entropy.

Authors:  Andy Schumann; Steffen Schulz; Andreas Voss; Susann Scharbrodt; Mathias Baumert; Karl-Jürgen Bär
Journal:  Front Physiol       Date:  2017-05-10       Impact factor: 4.566

5.  Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.

Authors:  Christoph U Correll; Marco Solmi; Nicola Veronese; Beatrice Bortolato; Stella Rosson; Paolo Santonastaso; Nita Thapa-Chhetri; Michele Fornaro; Davide Gallicchio; Enrico Collantoni; Giorgio Pigato; Angela Favaro; Francesco Monaco; Cristiano Kohler; Davy Vancampfort; Philip B Ward; Fiona Gaughran; André F Carvalho; Brendon Stubbs
Journal:  World Psychiatry       Date:  2017-06       Impact factor: 49.548

6.  Arrhythmogenic right ventricular cardiomyopathy in a patient with schizophrenia.

Authors:  Kenta Kawasaki; Kotaro Miyaji; Satoshi Kodera; Yoshio Suzuki; Junji Kanda; Masayuki Ikeda
Journal:  Clin Case Rep       Date:  2015-02-19

Review 7.  Cardiac Autonomic Dysfunction in Patients with Schizophrenia and Their Healthy Relatives - A Small Review.

Authors:  Karl-Jürgen Bär
Journal:  Front Neurol       Date:  2015-06-24       Impact factor: 4.003

8.  Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study.

Authors:  Jingping Zhao; Lehua Li; Jianguo Shi; Yi Li; Xiufeng Xu; Keqing Li; Lili Zhang; Shangli Cai; Yu Feng; Jianmin Zhuo; Weihong Liu; Huafei Lu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-02       Impact factor: 2.570

Review 9.  Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management.

Authors:  Antonio Ventriglio; Alessandro Gentile; Eleonora Stella; Antonello Bellomo
Journal:  Front Neurosci       Date:  2015-09-03       Impact factor: 4.677

10.  Olanzapine-induced weight gain plays a key role in the potential cardiovascular risk: evidence from heart rate variability analysis.

Authors:  Jun Wang; Yan-song Liu; Wen-xian Zhu; Fu-quan Zhang; Zhen-he Zhou
Journal:  Sci Rep       Date:  2014-12-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.